Why the study?
Does serum glutamic oxaloacetic transaminase (SGO-T) activity differentiate myocardial necrosis from coronary insufficiency, pericarditis, and pulmonary infarction?
Population
Experimental models and clinical patients with coronary insufficiency, pericarditis, and pulmonary infarction
Design
Other
Authors
Loading...
SGO-T activity is a valuable biomarker for differentiating myocardial necrosis from other causes of chest pain such as coronary insufficiency, pericarditis, and pulmonary infarction.
Does serum glutamic oxaloacetic transaminase (SGO-T) activity differentiate myocardial necrosis from coronary insufficiency, pericarditis, and pulmonary infarction?
SGO-T activity is a valuable biomarker for differentiating myocardial necrosis from other causes of chest pain such as coronary insufficiency, pericarditis, and pulmonary infarction.
Nydick et al. (1957) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: